CVS Group plc
CVSGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $582 | $342 | $327 | $160 |
| % Growth | 70.4% | 4.6% | 103.9% | – |
| Cost of Goods Sold | $375 | $193 | $181 | $189 |
| Gross Profit | $208 | $149 | $137 | $141 |
| % Margin | 35.7% | 43.5% | 41.9% | 88% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $114 | $122 | $115 | $113 |
| SG&A Expenses | $114 | $122 | $115 | $113 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $22 | $0 | $0 | $0 |
| Operating Expenses | $136 | $122 | $115 | $113 |
| Operating Income | $72 | $26 | $19 | $16 |
| % Margin | 12.4% | 7.7% | 5.9% | 9.9% |
| Other Income/Exp. Net | -$45 | -$9 | -$8 | -$5 |
| Pre-Tax Income | $27 | $17 | $11 | $27 |
| Tax Expense | $12 | $6 | $3 | $9 |
| Net Income | $15 | $11 | -$8 | $15 |
| % Margin | 2.6% | 3.3% | -2.6% | 9.1% |
| EPS | 0.15 | 0.16 | -0.11 | 0.2 |
| % Growth | -6.3% | 245.5% | -155% | – |
| EPS Diluted | 0.15 | 0.16 | -0.11 | 0.2 |
| Weighted Avg Shares Out | 72 | 72 | 72 | 72 |
| Weighted Avg Shares Out Dil | 72 | 72 | 72 | 72 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $15 | $9 | $2 | $10 |
| Depreciation & Amortization | $65 | $24 | $64 | $19 |
| EBITDA | $107 | $50 | $64 | $35 |
| % Margin | 18.3% | 14.7% | 19.7% | 22% |